Lisi, Lucia
 Distribuzione geografica
Continente #
EU - Europa 3.181
NA - Nord America 2.727
AS - Asia 544
SA - Sud America 6
AF - Africa 3
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.465
Nazione #
US - Stati Uniti d'America 2.703
PL - Polonia 1.233
DE - Germania 693
IT - Italia 392
SE - Svezia 308
CN - Cina 238
UA - Ucraina 172
SG - Singapore 115
GB - Regno Unito 94
IE - Irlanda 88
FR - Francia 79
IN - India 68
ID - Indonesia 59
FI - Finlandia 44
RU - Federazione Russa 32
VN - Vietnam 20
CA - Canada 17
TR - Turchia 17
BE - Belgio 15
ES - Italia 11
JP - Giappone 7
MX - Messico 7
NL - Olanda 7
HK - Hong Kong 6
CH - Svizzera 4
CL - Cile 4
IR - Iran 4
CZ - Repubblica Ceca 3
AU - Australia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
EG - Egitto 1
GR - Grecia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.465
Città #
Warsaw 1.218
Chandler 441
Ashburn 245
Fairfield 245
Jacksonville 135
Houston 133
Wilmington 131
Woodbridge 129
San Mateo 107
Cattolica 98
Seattle 92
Dublin 88
Singapore 87
Verona 84
Ann Arbor 82
Cambridge 82
Nanjing 63
Jakarta 59
Dearborn 49
Bremen 46
New York 46
Munich 42
Milan 40
Redwood City 40
Nürnberg 36
Rome 34
Lawrence 33
Nanchang 31
Boston 30
Chicago 24
Moscow 24
Beijing 23
Princeton 21
Lancaster 20
Dong Ket 17
Brussels 15
Marseille 15
Mountain View 15
Kraków 14
Pune 14
Redmond 14
Hangzhou 13
San Diego 13
University Park 13
Phoenix 12
Izmir 11
Los Angeles 11
Norwalk 11
Shanghai 11
Shenyang 11
Boardman 10
Changsha 10
Fremont 10
Jiaxing 10
Leawood 10
London 10
Busto Arsizio 9
Zhengzhou 9
Hebei 8
Toronto 8
Andover 6
Falls Church 6
Guangzhou 6
Monmouth Junction 6
Nanning 6
Corchiano 5
Gurgaon 5
Helsinki 5
Kunming 5
Paris 5
Philadelphia 5
Chiswick 4
Fondi 4
Hefei 4
Hong Kong 4
Jinan 4
Senigallia 4
Trento 4
Augusta 3
Detroit 3
Florence 3
Frankfurt am Main 3
Gustavo Adolfo Madero 3
Halifax 3
Madrid 3
Manchester 3
Orwell 3
Tianjin 3
Viterbo 3
Zurich 3
Addison 2
Akhisar 2
Anzio 2
Bogen 2
Brooklyn 2
Broomfield 2
Budapest 2
Cankaya 2
Cupertino 2
El Paraiso 2
Totale 4.506
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 352
mTOR kinase: a possible pharmacological target in the management of chronic pain 350
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 348
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 319
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 305
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 304
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 301
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 277
Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis 159
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis 140
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 133
Antiretrovirals inhibit arginase in human microglia 127
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 124
Variability of raltegravir plasma levels in the clinical setting 124
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 117
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 107
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 106
Pro-inflammatory activation of a new immortalized human microglia cell line 106
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 100
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 99
Antiretrovirals inhibit arginase in human microglia 98
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 97
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 93
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 91
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 91
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 90
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 89
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 87
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 82
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 82
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 82
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 79
Exploiting microglial functions for the treatment of glioblastoma 79
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 77
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 76
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 75
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 74
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 73
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 72
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 72
Exploiting Microglial Functions for the Treatment of Glioblastoma 70
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 65
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 65
Interactions between Integrase Inhibitors and human Arginase 1 64
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 64
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 62
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 61
DNA inhibitors for the treatment of brain tumors 60
The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids 58
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 57
Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples 53
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 52
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 51
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 44
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 32
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 26
The effects of painless nerve growth factor on human microglia polarization 23
A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19 8
The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment—A Systematic Review 5
Totale 6.577
Categoria #
all - tutte 22.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.070 0 0 142 188 66 90 105 51 142 59 158 69
2020/2021907 58 100 25 74 115 64 147 20 105 65 97 37
2021/2022755 74 56 13 29 66 30 11 97 30 60 170 119
2022/20231.127 128 163 107 188 76 137 25 95 137 20 27 24
2023/2024607 35 146 27 53 27 68 65 33 9 13 52 79
2024/2025156 23 34 99 0 0 0 0 0 0 0 0 0
Totale 6.577